BIO-TECHNE Corp — Director's Dealing 2013

Aug 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-08-01

Reporting Person: VERONNEAU MARCEL (VP Clinical Controls)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-08-01	Stock Option (Right to Buy)	$76.02	A	15000	Acquired	2020-07-31	Common Stock (15000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	34734	Direct
Common Stock	6827	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$56.83	2014-07-26	Common Stock (510)	510	Direct
Stock Option (Right to Buy)	$79.41	2015-07-24	Common Stock (385)	385	Direct
Stock Option (Right to Buy)	$62.46	2016-07-23	Common Stock (494)	494	Direct
Stock Option (Right to Buy)	$66.25	2017-04-29	Common Stock (10000)	10000	Direct
Stock Option (Right to Buy)	$58.40	2017-07-29	Common Stock (1281)	1281	Direct
Stock Option (Right to Buy)	$76.15	2018-07-27	Common Stock (20000)	20000	Direct
Stock Option (Right to Buy)	$76.15	2018-08-27	Common Stock (1129)	1129	Direct
Stock Option (Right to Buy)	$74.05	2019-07-26	Common Stock (1097)	1097	Direct

Footnotes

F1: Fully exercisable.

F2: Vests 5,000 on each of 6/30/12, 6/30/13, 6/30/14, and 6/30/15.

F3: Vests 3,750 on each of 8/1/14, 8/1/15, 8/1/16, and 8/1/17.